Wolters Kluwer Logo Wolters Kluwer Logo
Open search
Search suggestion
Open suggestion box
Search suggestion
log in button See related products
arrow down
Kluwer Patent Blog
Search filters
Clear all
GENERAL PREFERENCES
Search only titles
Jurisdiction
Category
Tags
Contributor
Date
From
To
End date must be later than the start date.

Search Results for: pemetrexed

34 results available

search-result-placeholder.jpg
Rik Lambers (Brinkhof)
πάντα ῥεῖ
January 17, 2023

Everything flows, and the Dutch cross-border injunction flows like no other. From its source in the The Hague all the way to the cradle of Europe: Greece. So decided the Dutch Courts in the Novartis…

  • Read more
search-result-placeholder.jpg
Jonathan Ross (Bristows)
On-line sales and threats: Don’t start to jump to conclusions
August 11, 2022

On 4 August 2022, the English Patents court handed down its decision in Shenzhen Carku Technology Co., Ltd v The NOCO Company, a case on battery-powered car jump starters. The decision of Mr Justice…

  • Read more
search-result-placeholder.jpg
Matthieu Dhenne (Dhenne Avocats)
Pemetrexed in France Act 2: 1 PI + 4 millions
February 08, 2021

Readers of the Blog should remember the French landmark French judgment rendered in September 2020 in the European Pemetrexed saga, which condemned Fresenius to pay € 28 million in damages (see here…

  • Read more
search-result-placeholder.jpg
Matthieu Dhenne (Dhenne Avocats)
TRU-VA-DI TRU-VA-DA, Life goes on at Gilead
December 22, 2020

Each time I hear “TRUVADA”, the catchy chorus of the Beatles’ Ob-La-Di Ob-La-Da sounds different to me... However, TV addicts or literature lovers also keen on pharmaceutical litigation should not…

  • Read more
search-result-placeholder.jpg
Rik Lambers (Brinkhof)
Pemetrexed – NL – Court of Appeal Inverts District Court
December 16, 2020

Yesterday, the Dutch prime minister announced the Netherlands will be ‘locked down’ until mid-January. At the same time the author of this blog, part of a six member audience due to COVID…

  • Read more
search-result-placeholder.jpg
Matthieu Dhenne (Dhenne Avocats)
Overview of FRAND litigation in France: is a new era coming?
November 19, 2020

2019 and 2020 were years marked by the development of international competition among jurisdictions for FRAND rate-setting. Although the voices of French Judges were still little heard in the midst…

  • Read more
search-result-placeholder.jpg
Matthieu Dhenne (Dhenne Avocats)
PEMETREXED patent infringement in France: €28 million in damages for Eli Lilly (“France is back”?)
October 26, 2020

Joining the majority of European courts, the Paris Court of Justice ruled that Eli Lilly's patent, which relates to the combined administration of pemetrexed disodium and vitamin B12, was infringed…

  • Read more
search-result-placeholder.jpg
Adrian Crespo (Clifford Chance)
Patent case: Ruling No. 76/2020 of Barcelona Commercial Court no. 4, Spain
August 26, 2020

Another chapter in the pemetrexed saga: Barcelona Commercial Court No. 4 has ruled on infringement in the very first case worldwide concerning pemetrexed diarginine, a salt form of pemetrexed chosen…

  • Read more
search-result-placeholder.jpg
Miquel Montañá (Clifford Chance)
The UK Supreme Court on pemetrexed: judicial colonialism or a step towards harmonization?
July 20, 2020

On 9 June 2020 Barcelona Commercial Court no. 4 issued a decision rejecting the opposition filed by a company (the "Defendant") against a decision of 2 September 2019 from the same Court that had…

  • Read more
search-result-placeholder.jpg
Rik Lambers (Brinkhof)
The Pemetrexed Pendulum Swings Back
June 21, 2019

Pemetrexed, yet again: last Wednesday the District Court of The Hague, swimming against the current and after a deep dive in the prosecution file, decided that Fresenius did not infringe Eli Lilly's…

  • Read more
1 - 10 of 34 results
  • 1
  • 2
  • 3
  • 4
  • About Kluwer Patent Blog
  • Contact Us
  • Wolters Kluwer: IP Law
    Wolters Kluwer: IP Law
  • Wolters Kluwer on X
    Wolters Kluwer: X
  • KLI YouTube
    YouTube
  • Editorial Policy & Guidelines
  • Privacy Policy and Use of Cookies
  • User Agreement and Disclaimer

© 2025 Wolters Kluwer N.V. and/or its subsidiaries. All rights reserved.